These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 27908267)

  • 1. Development of Poly(lactide-co-glicolide) Nanoparticles Incorporating Morphine Hydrochloride to Prolong its Circulation in Blood.
    Gomez-Murcia V; Montalban MG; Gomez-Fernandez JC; Almela P
    Curr Pharm Des; 2017; 23(13):2015-2025. PubMed ID: 27908267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency.
    Lee SY; Jung E; Park JH; Park JW; Shim CK; Kim DD; Yoon IS; Cho HJ
    J Colloid Interface Sci; 2016 Oct; 480():102-108. PubMed ID: 27421112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid.
    Dalpiaz A; Contado C; Mari L; Perrone D; Pavan B; Paganetto G; Hanuskovà M; Vighi E; Leo E
    Drug Deliv; 2014 May; 21(3):221-32. PubMed ID: 24134683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface coverage of didecyl dimethylammonium bromide on poly(lactide-co-glycolide) nanoparticles.
    Kuo YC; Yu HW
    Colloids Surf B Biointerfaces; 2011 May; 84(1):253-8. PubMed ID: 21288700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.
    Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM
    Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymeric nanoparticles of siRNA prepared by a double-emulsion solvent-diffusion technique: Physicochemical properties, toxicity, biodistribution and efficacy in a mammary carcinoma mice model.
    Ben David-Naim M; Grad E; Aizik G; Nordling-David MM; Moshel O; Granot Z; Golomb G
    Biomaterials; 2017 Nov; 145():154-167. PubMed ID: 28863309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced local bioavailability of single or compound drugs delivery to the inner ear through application of PLGA nanoparticles via round window administration.
    Cai H; Wen X; Wen L; Tirelli N; Zhang X; Zhang Y; Su H; Yang F; Chen G
    Int J Nanomedicine; 2014; 9():5591-601. PubMed ID: 25489245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methyl trypsin loaded poly(D,L-lactide-coglycolide) nanoparticles for contact lens care.
    Jimenez N; Galan J; Vallet A; Egea MA; Garcia ML
    J Pharm Sci; 2010 Mar; 99(3):1414-26. PubMed ID: 19774659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLGA biodegradable nanoparticles containing perphenazine or chlorpromazine hydrochloride: effect of formulation and release.
    Halayqa M; Domańska U
    Int J Mol Sci; 2014 Dec; 15(12):23909-23. PubMed ID: 25535080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
    Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
    Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymers.
    Ungaro F; d'Angelo I; Coletta C; d'Emmanuele di Villa Bianca R; Sorrentino R; Perfetto B; Tufano MA; Miro A; La Rotonda MI; Quaglia F
    J Control Release; 2012 Jan; 157(1):149-59. PubMed ID: 21864595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.
    Cun D; Foged C; Yang M; Frøkjaer S; Nielsen HM
    Int J Pharm; 2010 May; 390(1):70-5. PubMed ID: 19836438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells.
    Şengel-Türk CT; Hasçiçek C; Dogan AL; Esendagli G; Guc D; Gönül N
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1107-16. PubMed ID: 22348284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboplatin loaded Surface modified PLGA nanoparticles: Optimization, characterization, and in vivo brain targeting studies.
    Jose S; Juna BC; Cinu TA; Jyoti H; Aleykutty NA
    Colloids Surf B Biointerfaces; 2016 Jun; 142():307-314. PubMed ID: 26970818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.
    Kirby BP; Pabari R; Chen CN; Al Baharna M; Walsh J; Ramtoola Z
    J Pharm Pharmacol; 2013 Oct; 65(10):1473-81. PubMed ID: 24028614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PLGA-based nanoparticles as cancer drug delivery systems.
    Sadat Tabatabaei Mirakabad F; Nejati-Koshki K; Akbarzadeh A; Yamchi MR; Milani M; Zarghami N; Zeighamian V; Rahimzadeh A; Alimohammadi S; Hanifehpour Y; Joo SW
    Asian Pac J Cancer Prev; 2014; 15(2):517-35. PubMed ID: 24568455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional poly(D,L-lactide-co-glycolide)/montmorillonite (PLGA/MMT) nanoparticles decorated by Trastuzumab for targeted chemotherapy of breast cancer.
    Sun B; Ranganathan B; Feng SS
    Biomaterials; 2008 Feb; 29(4):475-86. PubMed ID: 17953985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan-poly (lactide-co-glycolide) (CS-PLGA) nanoparticles containing metformin HCl: preparation and in vitro evaluation.
    Gundogdu N; Cetin M
    Pak J Pharm Sci; 2014 Nov; 27(6):1923-9. PubMed ID: 25362616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, characterization, and in vivo study of rhein-loaded poly(lactic-co-glycolic acid) nanoparticles for oral delivery.
    Yuan Z; Gu X
    Drug Des Devel Ther; 2015; 9():2301-9. PubMed ID: 25960633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.